Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

被引:0
|
作者
Nanae Tomonaga
Yoichi Nakamura
Hiroshi Soda
Seiji Nagashima
Hirofumi Nakano
Akitoshi Kinoshita
Masaaki Fukuda
Minoru Fukuda
Hiroshi Takatani
Yoshifumi Soejima
Mikio Oka
Shigeru Kohno
机构
[1] Sasebo General Hospital,Department of Internal Medicine
[2] Nagasaki University School of Medicine,Second Department of Internal Medicine
[3] National Hospital Organization,Division of Respiratory Diseases, Department of Medicine
[4] Nagasaki Medical Center,undefined
[5] Japanese Red-Cross Nagasaki Atomic Bomb Hospital,undefined
[6] Kawasaki Medical School,undefined
[7] Nagasaki Municipal Hospital,undefined
[8] National Hospital Organization,undefined
[9] Ureshino Medical Center,undefined
来源
关键词
Non-small cell lung cancer; Chemotherapy; Vinorelbine; Irinotecan; Phlebitis; Clobetasol ointment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:43 / 49
页数:6
相关论文
共 50 条
  • [1] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Tomonaga, Nanae
    Nakamura, Yoichi
    Soda, Hiroshi
    Nagashima, Seiji
    Nakano, Hirofumi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Fukuda, Minoru
    Takatani, Hiroshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 43 - 49
  • [2] Phase I study of irinotecan and gemcitabine in previously untreated, patients with advanced non-small cell lung cancer
    Takatani, Hiroshi
    Soda, Hiroshi
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Nagashima, Seiji
    Fukuda, Minoru
    Soejima, Yoshifumi
    Nakano, Hirofumi
    Oka, Mikio
    Kohno, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) : 353 - 357
  • [3] A phase II study of vinorelbine in patients with advanced non-small cell lung cancer
    Evans, TRJ
    Mansi, JL
    Morgan, DAL
    Gyi, KM
    Banham, SW
    Milroy, R
    ONCOLOGY REPORTS, 1997, 4 (06) : 1337 - 1341
  • [4] Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer
    Kasai, T
    Oka, M
    Soda, H
    Tsurutani, J
    Fukuda, M
    Nakamura, Y
    Kawabata, S
    Nakatomi, K
    Nagashima, S
    Takatani, H
    Fukuda, M
    Kinoshita, A
    Kohno, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (14) : 1871 - 1878
  • [5] A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Govindan, R
    Lim, WT
    Arquette, MA
    Goodner, SA
    Fears, CL
    Mortimer, JE
    Fracasso, PM
    ONCOLOGY REPORTS, 2006, 15 (01) : 123 - 127
  • [6] Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer
    Hirose, T
    Horichi, N
    Ohmori, T
    Shirai, T
    Sohma, S
    Yamaoka, T
    Ohnishi, T
    Adachi, M
    LUNG CANCER, 2003, 39 (01) : 91 - 97
  • [7] Carboplatin and vinorelbine in advanced non-small cell lung cancer: A phase I/II study
    Masters, G
    ONCOLOGIST, 2001, 6 : 12 - 15
  • [8] A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer
    Hotta, K
    Sekine, I
    Tamura, T
    Sawada, M
    Watanabe, H
    Kusaba, H
    Akiyama, Y
    Inoue, A
    Shimoyama, T
    Nokihara, H
    Ueda, Y
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 596 - 600
  • [9] Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer
    Yanaihara, Tomoko
    Yokoba, Masanori
    Onoda, Sayaka
    Yamamoto, Michiko
    Ryuge, Shinichiro
    Hagiri, Shintaro
    Katagiri, Masato
    Wada, Mayuko
    Mitsufuji, Hisashi
    Kubota, Masaru
    Arai, Susumu
    Kobayashi, Hirosuke
    Yanase, Nobuo
    Abe, Tadashi
    Masuda, Noriyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 419 - 427
  • [10] Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer
    Tomoko Yanaihara
    Masanori Yokoba
    Sayaka Onoda
    Michiko Yamamoto
    Shinichiro Ryuge
    Shintaro Hagiri
    Masato Katagiri
    Mayuko Wada
    Hisashi Mitsufuji
    Masaru Kubota
    Susumu Arai
    Hirosuke Kobayashi
    Nobuo Yanase
    Tadashi Abe
    Noriyuki Masuda
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 419 - 427